Lasa Supergenerics Share Price History and Returns 2017 to 2025
Lasa Supergenerics Limited | |||
 | Price: ₹29.70 (+10.99%) | ||
| 52 Week Low: ₹19.00 52 Week High: ₹41.20 | |||
| Market Capital: 126.84 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Lasa Supergenerics Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Lasa Supergenerics Recent Performance
- 3: Lasa Supergenerics Stock Price Chart From 2017 to 2025
- 4: Lasa Supergenerics Stock Price History Table From 2017 to 2025
- 5: Analyzing the Impact of Investing in Lasa Supergenerics
- 5.1: Lasa Supergenerics Stock Returns In Last 5 Years
- 6: Lasa Supergenerics Returns vs Bank FD Returns
Lasa Supergenerics Stock Highlights
As of 02 Jan 2025, Lasa Supergenerics Stock price is ₹29.70 which is ₹11.50 below 52-week high of ₹41.20 and ₹10.70 above 52-week low of ₹19.00
52-Week High Low
- Lasa Supergenerics 52-Week High is ₹41.20 occurred on 09 Jan 2024
- Lasa Supergenerics 52-Week Low is ₹19.00 occurred on 05 Jun 2024
All Time High
- The all-time high or the highest price that Lasa Supergenerics stocks have ever touched was ₹214.00 and this occurred on Jan 2018.
- The highest closing price at which Lasa Supergenerics stocks have ever closed was ₹180.95 recorded on Dec 2017.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Lasa Supergenerics Recent Performance
Over the past 15 trading days, the value of Lasa Supergenerics's stock has increased by ₹2.52 (+9.27%). On 12 Dec 2024, its one share was worth ₹27.18 and by 02 Jan 2025, the value jumped to ₹29.7. During this period it created a highest high of ₹31.40 and lowest low of ₹24.30.
Click on legend items to show/hide respective price lines
Lasa Supergenerics Stock Price Chart From 2017 to 2025
Click on legend items to show/hide respective price lines
Lasa Supergenerics Stock Price History Table From 2017 to 2025
| Year | Lasa Supergenerics | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2025 | ₹29.70 | 10.9% | ↑ ₹31.40 ↓ ₹25.06 |
| 2024 | ₹26.76 | -10.6% | ↑ ₹41.20 ↓ ₹19.00 |
| 2023 | ₹29.90 | -11.2% | ↑ ₹34.35 ↓ ₹17.10 |
| 2022 | ₹33.65 | -51.0% | ↑ ₹84.15 ↓ ₹25.25 |
| 2021 | ₹68.60 | -19.0% | ↑ ₹100.00 ↓ ₹54.85 |
| 2020 | ₹84.60 | 372.6% | ↑ ₹93.20 ↓ ₹17.40 |
| 2019 | ₹17.90 | -40.7% | ↑ ₹36.55 ↓ ₹9.45 |
| 2018 | ₹30.15 | -83.4% | ↑ ₹214.00 ↓ ₹16.90 |
| 2017 | ₹180.95 | - | ↑ ₹188.00 ↓ ₹126.00 |
Analyzing the Impact of Investing in Lasa Supergenerics
Lasa Supergenerics Stock price in the year 2017 was ₹180.95. If you had invested ₹10,000 in Lasa Supergenerics Stock in 2017, in 8 years, your investment would have reduced to ₹1,641 by the end of 2025. This represents a negative return of -83.6% from 2017 to 2025, with a compound annual growth rate (CAGR) of -20.3%.
Lasa Supergenerics Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹100.90 and lowest was: ₹17.10
- Lasa Supergenerics Stock price in 2020 was ₹84.60
- By 2025, its stock price dropped to ₹29.70
- It gave a negative return of over -64.9% with a CAGR of -18.9% over the last 5 years
- If you had invested ₹10,000 in Lasa Supergenerics in 2020 then in 5 years, your investment would have declined to ₹3,510.63 by 2025.
Lasa Supergenerics Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Lasa Supergenerics Shares | ₹10,000 | ₹1,641.33 | -83.6% |
| Bank FD (Simple Interest) | ₹10,000 | ₹14,800 | 48.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹15,938.48 | 59.4% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
